{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:31:53Z","timestamp":1775766713833,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:00:00Z","timestamp":1343347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1136\/annrheumdis-2012-201457","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T06:40:29Z","timestamp":1343457629000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide"],"prefix":"10.1016","volume":"72","author":[{"given":"Sarah E","family":"Wythe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"DiCara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher E I","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara M","family":"Finucane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y K Stella","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahuva","family":"Nissim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Mather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuti","family":"Chernajovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201457_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med"},{"key":"10.1136\/annrheumdis-2012-201457_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1136\/annrheumdis-2012-201457_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","article-title":"Rheumatoid arthritis: regulation of synovial inflammation","volume":"36","author":"Sweeney","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1136\/annrheumdis-2012-201457_bib4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201457_bib5","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/ar1165","article-title":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis","volume":"6","author":"van Holten","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2012-201457_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.imlet.2009.10.006","article-title":"IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients","volume":"127","author":"Heo","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1136\/annrheumdis-2012-201457_bib7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.22034","article-title":"Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis","volume":"54","author":"Haas","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201457_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.188.6.1039","article-title":"Inhibition of angiogenesis by interleukin 4","volume":"188","author":"Volpert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2012-201457_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00918271","article-title":"Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"12","author":"Briolay","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/art.1780371202","article-title":"Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis","volume":"37","author":"Miossec","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201457_bib11","first-page":"2020","article-title":"Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells","volume":"22","author":"Sugiyama","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201457_bib12","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2009.27.3649","article-title":"Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma","volume":"28","author":"Gregorc","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1136\/annrheumdis-2012-201457_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1479-5876-7-68","article-title":"Phase I\/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma","volume":"7","author":"Ribas","year":"2009","journal-title":"J Transl Med"},{"key":"10.1136\/annrheumdis-2012-201457_bib14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.ejca.2010.07.012","article-title":"Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy","volume":"46","author":"Santoro","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/annrheumdis-2012-201457_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbspin.2009.05.011","article-title":"New insights in synovial angiogenesis","volume":"77","author":"Szekanecz","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1136\/annrheumdis-2012-201457_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","article-title":"Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?","volume":"10","author":"Marrelli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2012-201457_bib17","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/art.30650","article-title":"Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis","volume":"63","author":"Kamperidis","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201457_bib18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.10464","article-title":"Identification of synovium-specific homing peptides by in vivo phage display selection","volume":"46","author":"Lee","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201457_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1696028","article-title":"Searching for peptide ligands with an epitope library","volume":"249","author":"Scott","year":"1990","journal-title":"Science"},{"key":"10.1136\/annrheumdis-2012-201457_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"10.1136\/annrheumdis-2012-201457_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.iy.12.040194.002245","article-title":"Making antibodies by phage display technology","volume":"12","author":"Winter","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1039\/c0ib00013b","article-title":"Homing peptides as targeted delivery vehicles","volume":"2","author":"Laakkonen","year":"2010","journal-title":"Integr Biol (Camb)"},{"key":"10.1136\/annrheumdis-2012-201457_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/380364a0","article-title":"Organ targeting in vivo using phage display peptide libraries","volume":"380","author":"Pasqualini","year":"1996","journal-title":"Nature"},{"key":"10.1136\/annrheumdis-2012-201457_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2249.2000.01342.x","article-title":"Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice","volume":"122","author":"Wahid","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nbt888","article-title":"Targeting cytokines to inflammation sites","volume":"21","author":"Adams","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1136\/annrheumdis-2012-201457_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/kep117","article-title":"A novel model for the pre-clinical imaging of inflamed human synovial vasculature","volume":"48","author":"Garrood","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"10.1136\/annrheumdis-2012-201457_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng"},{"issue":"Suppl 2","key":"10.1136\/annrheumdis-2012-201457_bib28","doi-asserted-by":"crossref","first-page":"ii43","DOI":"10.1136\/ard.62.suppl_2.ii43","article-title":"Metalloproteinases, inflammation, and rheumatoid arthritis","volume":"62","author":"Mohammed","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201457_bib29","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.4049\/jimmunol.154.3.1432","article-title":"Balance of IL-1 receptor antagonist\/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10","volume":"154","author":"Chomarat","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib30","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.152.4.2060","article-title":"Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes\u2013regulation by IFN-gamma and IL-4","volume":"152","author":"Seitz","year":"1994","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib31","doi-asserted-by":"crossref","first-page":"12857","DOI":"10.1073\/pnas.1103569108","article-title":"Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis","volume":"108","author":"Yang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/annrheumdis-2012-201457_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrrheum.2011.119","article-title":"Experimental arthritis: addressing inflamed joints with peptides","volume":"7","author":"Leah","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201457_bib33","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.138.6.1813","article-title":"Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL 4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL 4)","volume":"138","author":"Mosmann","year":"1987","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/cimm.1993.1235","article-title":"Regulation of human IgE response in hu-PBL-SCID mice","volume":"151","author":"Kilchherr","year":"1993","journal-title":"Cell Immunol"},{"key":"10.1136\/annrheumdis-2012-201457_bib35","first-page":"31","article-title":"Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals","volume":"1","author":"Conlon","year":"1989","journal-title":"Biotechnol Ther"},{"key":"10.1136\/annrheumdis-2012-201457_bib36","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.ejca.2010.07.012","article-title":"Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy","volume":"46","author":"Santoro","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/annrheumdis-2012-201457_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"van Horssen","year":"2006","journal-title":"Oncologist"},{"key":"10.1136\/annrheumdis-2012-201457_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/BJ20070149","article-title":"Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb","volume":"406","author":"Liu","year":"2007","journal-title":"Biochem J"},{"key":"10.1136\/annrheumdis-2012-201457_bib39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301980","article-title":"Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis","volume":"10","author":"Smith","year":"2003","journal-title":"Gene Ther"},{"key":"10.1136\/annrheumdis-2012-201457_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1472-6750-11-104","article-title":"Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report","volume":"11","author":"Ventura","year":"2011","journal-title":"BMC Biotechnol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:42:35Z","timestamp":1739504555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724185731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0003496724185731"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201457","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954428.793460291","asserted-by":"object"}]},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}